167 related articles for article (PubMed ID: 9329128)
1. Multiple organ failure following zymosan-induced peritonitis is mediated by nitric oxide.
Cuzzocrea S; Zingarelli B; Sautebin L; Rizzo A; Crisafulli C; Campo GM; Costantino G; Calapai G; Nava F; Di Rosa M; Caputi AP
Shock; 1997 Oct; 8(4):268-75. PubMed ID: 9329128
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of poly(ADP-ribose) synthetase inhibition on multiple organ failure after zymosan-induced peritonitis in the rat.
Cuzzocrea S; Zingarelli B; Costantino G; Sottile A; Teti D; Caputi AP
Crit Care Med; 1999 Aug; 27(8):1517-23. PubMed ID: 10470759
[TBL] [Abstract][Full Text] [Related]
3. Inducible nitric oxide synthase knockout mice exhibit resistance to the multiple organ failure induced by zymosan.
Cuzzocrea S; Mazzon E; Dugo L; Barbera A; Centorrino T; Ciccolo A; Fonti MT; Caputi AP
Shock; 2001 Jul; 16(1):51-8. PubMed ID: 11442316
[TBL] [Abstract][Full Text] [Related]
4. Role of interleukin-6 in a non-septic shock model induced by zymosan.
Cuzzocrea S; de Sarro G; Costantino G; Mazzon E; Laurà R; Ciriaco E; de Sarro A; Caputi AP
Eur Cytokine Netw; 1999 Jun; 10(2):191-203. PubMed ID: 10400825
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of N-acetylcysteine on multiple organ failure induced by zymosan in the rat.
Cuzzocrea S; Costantino G; Mazzon E; Caputi AP
Crit Care Med; 1999 Aug; 27(8):1524-32. PubMed ID: 10470760
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of melatonin in a non-septic shock model induced by zymosan in the rat.
Cuzzocrea S; Zingarelli B; Costantino G; Caputi AP
J Pineal Res; 1998 Aug; 25(1):24-33. PubMed ID: 9694401
[TBL] [Abstract][Full Text] [Related]
7. Role of 5-lipoxygenase in the multiple organ failure induced by zymosan.
Cuzzocrea S; Rossi A; Serraino I; Di Paola R; Dugo L; Genovese T; Britti D; Sciarra G; De Sarro A; Caputi AP; Sautebin L
Intensive Care Med; 2004 Oct; 30(10):1935-43. PubMed ID: 15241586
[TBL] [Abstract][Full Text] [Related]
8. Effects of calpain inhibitor I on multiple organ failure induced by zymosan in the rat.
Cuzzocrea S; Chatterjee PK; Mazzon E; Serraino I; Dugo L; Centorrino T; Barbera A; Ciccolo A; Fulia F; McDonald MC; Caputi AP; Thiemermann C
Crit Care Med; 2002 Oct; 30(10):2284-94. PubMed ID: 12394957
[TBL] [Abstract][Full Text] [Related]
9. Role of nitric oxide in a nonseptic shock model induced by zymosan in the rat.
Cuzzocrea S; Filippelli A; Zingarelli B; Falciani M; Caputi AP; Rossi F
Shock; 1997 May; 7(5):351-7. PubMed ID: 9165670
[TBL] [Abstract][Full Text] [Related]
10. The tyrosine kinase inhibitor tyrphostin AG 126 reduces the multiple organ failure induced by zymosan in the rat.
Dugo L; Chatterjee PK; Mazzon E; McDonald MC; Paola RD; Fulia F; Caputi AP; Thiemermann C; Cuzzocrea S
Intensive Care Med; 2002 Jun; 28(6):775-88. PubMed ID: 12107686
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide synthase and cyclo-oxygenase pathways in the inflammatory response induced by zymosan in the rat air pouch.
Payá M; García Pastor P; Coloma J; Alcaraz MJ
Br J Pharmacol; 1997 Apr; 120(8):1445-52. PubMed ID: 9113364
[TBL] [Abstract][Full Text] [Related]
12. Role of induced nitric oxide synthase and increased NO levels in zymosan peritonitis in the rat.
Boughton-Smith NK; Ghelani A
Inflamm Res; 1995 Aug; 44 Suppl 2():S149-50. PubMed ID: 8548372
[No Abstract] [Full Text] [Related]
13. PD98059, a specific MAP kinase inhibitor, attenuates multiple organ dysfunction syndrome/failure (MODS) induced by zymosan in mice.
Di Paola R; Galuppo M; Mazzon E; Paterniti I; Bramanti P; Cuzzocrea S
Pharmacol Res; 2010 Feb; 61(2):175-87. PubMed ID: 19819333
[TBL] [Abstract][Full Text] [Related]
14. Zymosan induces nitric oxide production by peritoneal mesothelial cells.
Yao V; McCauley R; Cooper D; Platell C; Hall JC
ANZ J Surg; 2004 Apr; 74(4):266-9. PubMed ID: 15043739
[TBL] [Abstract][Full Text] [Related]
15. Pyrrolidine dithiocarbamate attenuates the development of organ failure induced by zymosan in mice.
Cuzzocrea S; Rossi A; Pisano B; Di Paola R; Genovese T; Patel NS; Cuzzocrea E; Ianaro A; Sautebin L; Fulia F; Chatterjee PK; Caputi AP; Thiemermann C
Intensive Care Med; 2003 Nov; 29(11):2016-25. PubMed ID: 12879239
[TBL] [Abstract][Full Text] [Related]
16. Glutamine treatment attenuates the development of organ injury induced by zymosan administration in mice.
Mondello S; Galuppo M; Mazzon E; Italiano D; Mondello P; Aloisi C; Cuzzocrea S
Eur J Pharmacol; 2011 May; 658(1):28-40. PubMed ID: 21349270
[TBL] [Abstract][Full Text] [Related]
17. Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors.
Salvemini D; Manning PT; Zweifel BS; Seibert K; Connor J; Currie MG; Needleman P; Masferrer JL
J Clin Invest; 1995 Jul; 96(1):301-8. PubMed ID: 7542281
[TBL] [Abstract][Full Text] [Related]
18. Role of hyperbaric oxygen exposure in reduction of lipid peroxidation and in multiple organ failure induced by zymosan administration in the rat.
Cuzzocrea S; Imperatore F; Costantino G; Luongo C; Mazzon E; Scafuro MA; Mangoni G; Caputi AP; Rossi F; Filippelli A
Shock; 2000 Mar; 13(3):197-203. PubMed ID: 10718376
[TBL] [Abstract][Full Text] [Related]
19. Role of inducible nitric oxide synthase in the regulation of neutrophil migration in zymosan-induced inflammation.
Ajuebor MN; Virág L; Flower RJ; Perretti M; Szabó C
Immunology; 1998 Dec; 95(4):625-30. PubMed ID: 9893055
[TBL] [Abstract][Full Text] [Related]
20. Absence of peroxisome proliferators-activated receptors (PPAR)alpha enhanced the multiple organ failure induced by zymosan.
Di Paola R; Esposito E; Mazzon E; Genovese T; Muià C; Crisafulli C; Malleo G; Sessa E; Meli R; Cuzzocrea S
Shock; 2006 Nov; 26(5):477-84. PubMed ID: 17047518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
